Key Highlights from EULAR 2024 Conference Studies on Rheumatoid Arthritis and Psoriatic Arthritis Treatments

The chapter provides insights into studies presented at the EULAR 2024 conference, focusing on treatments for rheumatoid arthritis and psoriatic arthritis. It covers the effectiveness of baricitinib in reducing pain for patients, compares different medications like abatricept and adalimumab, and discusses safety data on UPPA. Additionally, real-world data on treatments like selective TIC2 inhibitors for rheumatoid arthritis and new medications like Sonolucumab for psoriatic arthritis are explored, highlighting promising outcomes and challenges in managing these conditions.